Advarra

SEPTEMBER 14, 2023

In the clinical research space, GxP is a set of quality regulations and guidelines designed to establish the safety, efficacy, and integrity of pharmaceuticals, medical devices, and clinical trials. This blog explores key concepts, regulations, and the importance of GxP in delivering successful clinical trials.

Clinical Research 52

Clinical Research Compliance Research Regulation 52

pharmaphorum

DECEMBER 9, 2021

Instead, Britain needs to “strike a balance between forging its own path as a sovereign regulator whilst ensuring strategic partnerships with other leading regulators, including the European Medicines Agency (EMA), are nurtured” it recommends. “As The same principle applies to regulation,” she went on.

Regulation 98

Regulation Medicine Life Science Development 98

Drug Discovery World

OCTOBER 19, 2022

Following the news that the number of clinical trial recruiting sites in Ukraine has dropped by half since the Russian invasion, DDW’s Diana Spencer examines clinical trial data from analytics company Phesi and speaks to Dr Olena Karpenko , Clinical Research Director at Medical Center Ok!Clinic+ Dr Olena Karpenko.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

pharmaphorum

DECEMBER 22, 2022

The life sciences industry is flexing towards innovation in new areas, faster than ever before, and increasing patient care in astonishing ways. The life sciences industry will collaborate and share lessons learned with other verticals that are currently exploring the same concept, such as “Self-Sovereign Identity” (SSI).

Clinical Research 97

Clinical Research Research Clinical Trials Clinical Trials 97

Pharmaceutical Technology

NOVEMBER 17, 2022

Horizon Therapeutics and Johns Hopkins University School of Medicine have entered a multi-year scientific partnership for advancing autoimmunity and inflammation research. The research scientists at the company and experts at Johns Hopkins University School of Medicine aim to identify new metabolic pathways.

Research 130

Research Life Science Medicine Scientist 130

XTalks

AUGUST 22, 2023

Yet, 41 percent of people in the US have no knowledge of the clinical research process, and 91 percent say they’ve never been given the opportunity to participate in a trial, according to SCORR Marketing. The availability of new medicines is reliant upon individuals’ willingness to contribute to clinical trials.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Clinical Research 97

ACRP blog

APRIL 30, 2024

Staffing and retention have been the top concern at research sites since 2020, with patient recruitment and enrollment ranking second, and the complexity of clinical trials ranking third, based on WCG survey data for 2020 to 2023. based clinical research sites.

Clinical Research 59

Clinical Research Clinical Trials Clinical Trials Clinical Research Coordinator 59

XTalks

MARCH 19, 2024

Additionally, she examines the limitations of prevalent paper-based assessments in current clinical practice and research, providing insight into the cascading impact of these challenges on the broader clinical research landscape.

Drugs 115

Drugs Clinical Trials Clinical Trials Clinical Research 115

Drug Discovery World

AUGUST 3, 2023

In the first part of this series of articles focused on plant-based medicines, DDW’s Megan Thomas evaluates the use of medical cannabis in drug discovery. Medical cannabis is often a first-thought when regarding plant-based medicines, but there remains public scepticism, arguably due to the regulations relating to the substance.

Medicine 52

Medicine Scientist Production Regulation 52

ACRP blog

MAY 5, 2024

Some of the other educational sessions from the Saturday morning lineup of topics concentrated on the intricacies of pitching the availability of clinical trials to potential participants, and on incorporating the principles of best patient engagement practices into the training of clinical research professionals.

Clinical Research 59

Clinical Research Clinical Research Coordinator Clinical Trials Clinical Trials 59

XTalks

MAY 20, 2022

Doctors and physicians rely on the results provided by a clinical scientist to make an accurate prognosis, diagnosis and assessment for a patient’s treatment plan. What is it Like to Work as a Clinical Scientist? A clinical scientist is often synonymous with: Clinical Research / Clinical Laboratory Scientist.

Scientist 105

Scientist Life Science Clinical Research Doctors 105

Pharma in Brief

JUNE 26, 2022

The government’s goals include reinforcing Canada’s clinical trials infrastructure so as to improve the health and safety of all Canadians while also ensuring that Canada is well-positioned to respond to any future pandemics or other health crises by having the best available treatments. The Clinical Trials Fund.

Clinical Trials 52

Clinical Trials Clinical Trials Trial Funding Trials 52

Drug Discovery World

OCTOBER 16, 2023

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has revealed plans to reduce the time taken to approve the lowest-risk clinical trials by more than 50%. The MHRA predicts about 20% of UK initial clinical trial applications will be eligible for the scheme.

Clinical Trials 52

Clinical Trials Clinical Trials Regulation Trials 52

Drug Discovery World

OCTOBER 6, 2023

NPIP’s network of infrastructure and intelligence will also connect insights from many research programmes and trials, building a rich bank of data that the PET community can access. The post Total-body PET scanners will enhance UK drug discovery appeared first on Drug Discovery World (DDW).

Drugs 52

Drugs Clinical Trials Clinical Trials Life Science 52

pharmaphorum

DECEMBER 11, 2022

So, when a life sciences company embarks on a project of digital transformation or innovation, it’s really embarking on multiple projects that span the wide world of pharmaceutical operations. AI gets us closer to personalised medicine.”. I don’t think a life science company can solve it alone.

Life Science 137

Life Science Clinical Research Development Research 137

XTalks

MAY 17, 2023

The Foundation for the National Institutes of Health (FNIH) announced this week that the Accelerating Medicines Partnership Bespoke Gene Therapy Consortium (AMP BGTC) has selected eight rare diseases for its clinical trial portfolio.

Gene Therapy 98

Gene Therapy Clinical Trials Clinical Trials Gene 98

pharmaphorum

DECEMBER 1, 2022

To ease this burden, the life sciences industry has been searching for ways to make clinical trials more accessible for patients and to drive participation numbers, increase participant diversity, and improve overall patient experience. Imagine, clinical research as an accessible care option to anyone.

Clinical Trials 111

Clinical Trials Clinical Trials Trials Clinical Research 111

XTalks

MAY 7, 2024

XTALKS CLINICAL EDGE: Issue 2 — Special Focus on Rare Disease Clinical Research Xtalks Clinical Edge is a magazine for clinical research professionals and all who want to be informed about the latest trends and happenings in clinical trials. It is an essential part of Alexion’s commitment.

Clinical Trials 52

Clinical Trials Clinical Trials Medicine Clinical Research 52

Advarra

FEBRUARY 28, 2023

This February, Advarra’s “Honoring Clinical Trailblazers” video series paid tribute to the outstanding achievements of four pioneering African American physicians who defied the odds to make significant contributions to the field of medicine. and abroad.

Medicine 52

Medicine Clinical Research Life Science Research 52

pharmaphorum

NOVEMBER 1, 2022

The two venerable Indiana institutions – Lilly headquartered in Indianapolis and Purdue in nearby West Lafayette – have been working together for many years, collaborating on life sciences research in areas such as new delivery systems for injectable medicines and predictive models for clinical research.

Manufacturing 52

Manufacturing Life Science Drug Delivery Medicine 52

XTalks

OCTOBER 17, 2022

The global virtual clinical trials market is valued at $8.3 The COVID-19 pandemic has significantly impacted the market and many clinical research organizations (CROs) were quick to embrace decentralization capabilities. billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.7 billion by 2030.

Trials 98

Trials Research Clinical Trials Clinical Trials 98

XTalks

JANUARY 17, 2024

In this Xtalks Spotlight edition, Xtalks spoke with two oncology clinical research experts from Fortrea , Laura Vidal, MD, Medical Head of Oncology, EU (European Union), and Ken Morrison, PhD, Global Head of Strategic Delivery & Growth Oncology.

Clinical Trials 124

Clinical Trials Clinical Trials Trials Gene Therapy 124

Imperical Blog

JANUARY 15, 2020

Happy 2020 from Imperial Clinical Research Services! Imperial proudly provides clinical research-oriented blogs and ebooks provided by our diverse and knowledgeable subject matter experts (SMEs). The Secret to International Clinical Trial Shipments Clearing Customs.

Clinical Trials 52

Clinical Trials Clinical Trials Branding Clinical Research 52

XTalks

MARCH 20, 2024

When it comes to leadership in clinical trials today, what qualities are necessary to navigate the evolving landscape of clinical research effectively? Xtalks recently had the opportunity to discuss Enciso’s journey in the clinical research industry and her decision to join Regeneron.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

pharmaphorum

OCTOBER 27, 2022

However, fostering lasting and meaningful partnerships is not a simple task for life science companies. For centuries, botany played a fundamental role in the development of medicine. We explore how researchers unlocked the pharmaceutical properties of five key plants and how these plants continue to serve patients worldwide.

Life Science 105

Life Science Research Development Clinical Research 105

ACRP blog

APRIL 5, 2023

AI is increasingly important in drug discovery and development as well as clinical trials, operations, pharmacovigilance, and many other areas.” This has led to the emergence of a new ‘pharmaceutical intelligence’ that has allowed the industry to move away from traditional, slow-moving, and costly processes,” Lyons writes. “AI

Big Data 52

Big Data Clinical Trials Clinical Trials Life Science 52

XTalks

MAY 9, 2024

As we explore Genmab’s strategic vision, technological advancements and the next frontier in antibody research, we gain insights into the future of medicine — a future where Genmab’s cutting-edge therapies are poised to transform patient care and meet the complex challenges of the next generation of healthcare.

Antibody 52

Antibody Clinical Trials Clinical Trials Medicine 52

pharmaphorum

MAY 27, 2022

This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials. There is a huge opportunity for pharma companies to capitalise on by focusing on increased DEI in clinical trials. You can read part one of this article here.

Clinical Trials 80

Clinical Trials Clinical Trials Trials Packaging 80

pharmaphorum

FEBRUARY 1, 2022

Attendees will learn more about how an SCA was used at the design and execution phases in a recent study of new treatments for relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL) and will also receive an eBook ‘How to harness the potential of AI and real-world data for clinical research’. About the panel.

Clinical Trials 104

Clinical Trials Clinical Trials Trials Engineer 104

Drug Discovery World

DECEMBER 20, 2022

As 2022 draws to a close, life sciences market analysts attempt to correctly predict what the next 12 months might bring to the drug discovery sector. There will be greater emphasis on diversity in clinical trials. Personalised and precision medicines will dominate pipelines.

Drugs 52

Drugs Gene Editing Clinical Trials Clinical Trials 52

XTalks

AUGUST 2, 2023

With over 30 years of clinical research experience, Dr. Karen Correa, PhD, BCMAS, Vice President, Head of Global Clinical Operations at Takeda, is undoubtedly an authority on the topic of leadership in this complex and unpredictable industry. Read on to understand what strong leadership means in the clinical trials arena.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Clinical Research 97

pharmaphorum

OCTOBER 2, 2020

The five new NIHR National Patient Recruitment Centres (NPRCs) are set to shape the future of commercial clinical trials in the UK by offering new ways to conduct late-phase, large-scale research projects. Yan Yiannkou is a consultant gastroenterologist and Clinical Director of the NIHR Patient Recruitment Centre (Newcastle).

Clinical Trials 92

Clinical Trials Clinical Trials Life Science Clinical Research 92

Drug Discovery World

OCTOBER 16, 2023

Indeed, this is bolstered by top tier universities like Newcastle University, which specialises in structure-based approaches for drug discovery, developing innovative technologies that support the identification of new medicines, and is well-established in cancer drug discovery. Government investment of £1.3

Drugs 75

Drugs Life Science Gene Therapy Genome 75

pharmaphorum

OCTOBER 27, 2022

However, there is a general prohibition in the legislation of using celebrities to promote medicines. Jackie Mulryne, Partner, is a member of the Life Sciences practice group, and provides regulatory, policy, and compliance advice to clients in the pharmaceutical, medical technology, cosmetics, and foods sectors.

Life Science 98

Life Science Compliance Regulation Cosmetics 98

pharmaphorum

MARCH 3, 2022

The UK biopharma industry has welcomed a new tranche of funding from the government aimed at bolstering manufacturing of medicinal products and developing the national health data infrastructure.

Manufacturing 52

Manufacturing Life Science Clinical Trials Clinical Trials 52

XTalks

NOVEMBER 27, 2023

While they have expanded to support many therapeutic areas, Worldwide built its name by delivering exceptional neuroscience development services in partnership with the sponsors leading the charge in changing medicine. These innovative strategies could offer effective pain relief without the risks associated with traditional opioids.

Clinical Trials 102

Clinical Trials Clinical Trials Trials Clinical Research 102

XTalks

JANUARY 16, 2024

This approach has resulted in more effective treatments and could serve as a model to enable personalized medicine for patients with neurodegenerative diseases and neuropsychiatric conditions. His insights reflect a broader call within the industry to embrace new technologies and patient-centric approaches to advance CNS clinical research.

Development 122

Development Drugs Clinical Trials Clinical Trials 122